18F-flurpiridaz positron emission tomography segmental and territory myocardial blood flow metrics: incremental value beyond perfusion for coronary artery disease categorization

By sjmartinez • November 22, 2022

Packard RRS, Votaw JR, Cooke CD, Van Train KF, Garcia EV, Maddahi J. 18F-flurpiridaz positron emission tomography segmental and territory myocardial blood flow metrics: incremental value beyond perfusion for coronary artery disease categorization. Eur Heart J Cardiovasc Imaging. 2022 Nov 17;23(12):1636-1644. doi: 10.1093/ehjci/jeab267. PMID: 34928321; PMCID: PMC9671402.

Tags: Cardiology/Epi, diagnostic performance, flurpiridaz, myocardial blood flow, perfusion, PET, Publications, segmental

Association of RSV Vaccination With Clinical Outcomes in Older Adults With Heart Failure: A Propensity-Matched Analysis

Khan A, Shabbir MR, Nasrallah J, Imtiaz M, Thyagaturu H, Fudim M, Mentz RJ, Fonarow GC. Association of RSV Vaccination With Clinical Outcomes in Older[...]

Trends in Guideline Directed Medical Therapy Use in Heart Failure With a Mildly Reduced Ejection Fraction

Girard AA, Martinez OC, Ikeaba U, Jawad MA, Ikemura N, Chiswell K, Greene SJ, Fonarow GC, Chan PS, Sauer AJ, Spertus JA. Trends in Guideline[...]

Coronary Artery Calcium in ACC/AHA Prevention Guidelines: Evolution From 2007 to 2026

Irannejad K, Mora R, Krishnan S, Lakshmanan S, Roy S, Budoff MJ. Coronary Artery Calcium in ACC/AHA Prevention Guidelines: Evolution From 2007 to 2026. JACC[...]